Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 12/2022

Open Access 02-12-2022 | Childhood Asthma | Asthma (V Ortega, Section Editor)

Recent miRNA Research in Asthma

Authors: Rinku Sharma, Anshul Tiwari, Michael J. McGeachie

Published in: Current Allergy and Asthma Reports | Issue 12/2022

Login to get access

Abstract

Purpose of Review

The study of microRNA in asthma has revealed a vibrant new level of gene regulation underlying asthma pathology. Several miRNAs have been shown to be important in asthma, influencing various biological mechanisms which lead to asthma pathology and symptoms. In addition, miRNAs have been proposed as biomarkers of asthma affection status, asthma severity, and asthma treatment response. We review all recent asthma-miRNA work, while also presenting comprehensive tables of all miRNA results related to asthma.

Recent Findings

We here reviewed 63 recent studies published reporting asthma and miRNA research, and an additional 14 reviews of the same. We summarized the information for both adult and childhood asthma, as well as research on miRNAs in asthma–COPD overlap syndrome (ACOs), and virus-induced asthma exacerbations.

Summary

We attempted to present a comprehensive collection of recently published asthma-associated miRNAs as well as tables of all published asthma-related miRNA results.
Literature
1.
Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest. 2008;134(3 Suppl):1S-41S.CrossRef
2.
GAN. The Global Asthma Report. Vol. 9, Policy Studies. Auckland, New Zealand; 2018.
3.
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–78.CrossRef
4.
Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226–35.CrossRef
5.
6.
7.
Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10(2):126–39.CrossRef
8.
9.
Ardekani AM, Naeini MM. The role of MicroRNAs in human diseases. Avicenna J Med Biotechnol. 2010;2(4):161–79.
10.
Cañas JA, Rodrigo-Muñoz JM, Gil-Martínez M, Sastre B, del Pozo V. Exosomes: a key piece in asthmatic inflammation. Int J Mol Sci. 2021;22(2):963.CrossRef
11.
Bélanger É, Madore A-M, Boucher-Lafleur A-M, Simon M-M, Kwan T, Pastinen T, et al. Eosinophil microRNAs play a regulatory role in allergic diseases included in the atopic march. Int J Mol Sci. 2020;21(23):9011.CrossRef
12.
Tan BWQ, Sim WL, Cheong JK, Kuan WS, Tran T, Lim HF. MicroRNAs in chronic airway diseases: clinical correlation and translational applications. Pharmacol Res. 2020;160:105045.CrossRef
13.
Usman K, Hsieh A, Hackett T-L. The role of miRNAs in extracellular matrix repair and chronic fibrotic lung diseases. Cells. 2021;10(7):1706.CrossRef
14.
Adcock IM, Mumby S. MicroRNAs in human disease: commentary. Iran J Allergy Asthma Immunol. 2021;20(3):259–62.
15.
Alashkar Alhamwe B, Potaczek DP, Miethe S, Alhamdan F, Hintz L, Magomedov A, et al. Extracellular vesicles and asthma-more than just a co-existence. Int J Mol Sci. 2021;22(9):4984.CrossRef
16.
Cañas JA, Rodrigo-Muñoz JM, Sastre B, Gil-Martinez M, Redondo N, Del Pozo V. MicroRNAs as potential regulators of immune response networks in asthma and chronic obstructive pulmonary disease. Front Immunol. 2020;11:608666.CrossRef
17.
Paul S, Ruiz-Manriquez LM, Ledesma-Pacheco SJ, Benavides-Aguilar JA, Torres-Copado A, Morales-Rodríguez JI, et al. Roles of microRNAs in chronic pediatric diseases and their use as potential biomarkers: a review. Arch Biochem Biophys. 2021;699:108763.CrossRef
18.
Akbari Dilmaghnai N, Shoorei H, Sharifi G, Mohaqiq M, Majidpoor J, Dinger ME, et al. Non-coding RNAs modulate function of extracellular matrix proteins. Biomed Pharmacother. 2021;136:111240.CrossRef
19.
•• Calvén J, Ax E, Rådinger M. The airway epithelium–a central player in asthma pathogenesis. Int J Mol Sci. 2020;21(23):8907. Describes the miRNAs associated with virus induced asthma and role of airway epithelium.CrossRef
20.
Benincasa G, DeMeo DL, Glass K, Silverman EK, Napoli C. Epigenetics and pulmonary diseases in the horizon of precision medicine: a review. Eur Respir J. 2021;57(6):2003406.CrossRef
21.
Shastri MD, Chong WC, Dua K, Peterson GM, Patel RP, Mahmood MQ, et al. Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators. Inflammopharmacology. 2021;29(1):15–33.CrossRef
22.
•• Weidner J, Bartel S, Kılıç A, Zissler UM, Renz H, Schwarze J, et al. Spotlight on microRNAs in allergy and asthma. Allergy. 2021;76(6):1661–78. COMMENT: A good collection of miRNAs associated with Asthma.
23.
Alashkar Alhamwe B, Miethe S, von Strandmann E, Potaczek DP, Garn H. Epigenetic regulation of airway epithelium immune functions in asthma. Front Immunol. 2020;11:1747.CrossRef
24.
Ghafouri-Fard S, Shoorei H, Taheri M, Sanak M. Emerging role of non-coding RNAs in allergic disorders. Biomed Pharmacother. 2020;130:110615.CrossRef
25.
Casciaro M, Di Salvo E, Pioggia G, Gangemi S. Microbiota and microRNAs in lung diseases: mutual influence and role insights. Eur Rev Med Pharmacol Sci. 2020;24(24):13000–8.
26.
Kuruvilla ME, Lee FE-H, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–33.CrossRef
27.
28.
29.
30.
31.
Rodrigo-Muñoz JM, Cañas JA, Sastre B, Rego N, Greif G, Rial M, et al. Asthma diagnosis using integrated analysis of eosinophil microRNAs. Allergy. 2019;74(3):507–17.CrossRef
32.
Taka S, Tzani-Tzanopoulou P, Wanstall H, Papadopoulos NG. MicroRNAs in asthma and respiratory infections: identifying common pathways. Allergy Asthma Immunol Res. 2020;12(1):4–23.CrossRef
33.
Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231(1):25–30.CrossRef
34.
35.
36.
Ibrahim AA, Ramadan A, Wahby AA, Draz IH, El Baroudy NR, Abdel Hamid TA. Evaluation of miR-196a2 expression and Annexin A1 level in children with bronchial asthmaEvaluation of miR-196a2 expression and Annexin A1 level in children. Allergol Immunopathol (Madr). 2020;48(5):458–64.CrossRef
37.
Wang T, Zhou Q, Shang Y. Downregulation of miRNA-451a promotes the differentiation of CD4+ T cells towards Th2 cells by upregulating ETS1 in childhood asthma. J Innate Immun. 2021;13(1):38–48.CrossRef
38.
Wang AL, Li J, Kho AT, McGeachie MJ, Tantisira KG. Enhancing the prediction of childhood asthma remission: integrating clinical factors with microRNAs. J Allergy Clin Immunol. 2021;147(3):1093-1095.e1.CrossRef
39.
Tiwari A, Li J, Kho AT, Sun M, Lu Q, Weiss ST, et al. COPD-associated miR-145-5p is downregulated in early-decline FEV1 trajectories in childhood asthma. J Allergy Clin Immunol. 2021;147(6):2181–90.CrossRef
40.
Elnady HG, Sherif LS, Kholoussi NM, Ali Azzam M, Foda AR, Helwa I, et al. Aberrant expression of immune-related MicroRNAs in pediatric patients with asthma. Int J Mol Cell Med. 2020;9(4):246–55.
41.
Li W, Wang X, Sun S, An H. Long non-coding RNA colorectal neoplasia differentially expressed correlates negatively with miR-33a and miR-495 and positively with inflammatory cytokines in asthmatic children. Clin Respir J. 2021;15(11):1175–84.CrossRef
42.
Yin H, Liu MH, Gao F, Shang HM. Pro-inflammatory and pro-fibrotic role of long non-coding RNA RMRP in pediatric asthma through targeting microRNA-206/CCL2 axis. J Biol Regul Homeost Agents. 2021;35(1):71–83.
43.
Tiwari A, Wang AL, Li J, Lutz SM, Kho AT, Weiss ST, et al. Seasonal variation in miR-328-3p and let-7d-3p are associated with seasonal allergies and asthma symptoms in children. Allergy Asthma Immunol Res. 2021;13(4):576–88.CrossRef
44.
Sharma S, Kho AT, Chhabra D, Haley K, Vyhlidal C, Gaedigk R, et al. Effect of intrauterine smoke exposure on microRNA-15a expression in human lung development and subsequent asthma risk. Healthc. 2020;8(4):536.CrossRef
45.
Zhai C, Wang D. Baicalin regulates the development of pediatric asthma via upregulating microRNA-103 and mediating the TLR4/NF-κB pathway. J Recept Signal Transduct Res. 2021;1–11.
46.
Dong J, Sun D, Lu F. Association of two polymorphisms of miRNA-146a rs2910164 (G > C) and miRNA-499 rs3746444 (T > C) with asthma: a meta-analysis. J Asthma. 2021;58(8):995–1002.CrossRef
47.
Rahbarghazi R, Keyhanmanesh R, Rezaie J, Mirershadi F, Heiran H, Saghaei Bagheri H, et al. c-kit+ cells offer hopes in ameliorating asthmatic pathologies via regulation of miRNA-133 and miRNA-126. Iran J Basic Med Sci. 2021;24(3):369–76.
48.
Wang K, Zhu H, Yang L, Xu Q, Ren F. miR-139 promotes homing of bone marrow mesenchymal stem cells (BMSCs) to lung tissues of asthmatic rats to inhibit inflammatory response of Th2 cells by down-regulating Notch1/Hes1 pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021;37(2):97–104.
49.
Aripova A, Akparova A, Bersimbaev R. Moderate bronchial asthma. MicroRNA. 2020;9(5):373–7.CrossRef
50.
Li J, Tiwari A, Mirzakhani H, Wang AL, Kho AT, McGeachie MJ, et al. Circulating MicroRNA: incident asthma prediction and vitamin D effect modification. J Pers Med. 2021;11(4):307.CrossRef
51.
Rostami Hir S, Alizadeh Z, Mazinani M, Mahlooji Rad M, Fazlollahi MR, Kazemnejad A, et al. Exosomal MicroRNAs as biomarkers in allergic asthma. Iran J Allergy Asthma Immunol. 2021;20(2):160–8.
52.
Li S, Ma X, Xie J, Yan X, Sun W. MicroRNA-206, IL-4, IL-13, and INF-γ levels in lung tissue and plasma are increased by the stimulation of particulate matter with a diameter of ≤2.5μm, and are associated with the poor prognosis of asthma induced pulmonary arterial hypert. Clin Exp Hypertens. 2021;43(2):181–8.CrossRef
53.
Bahmer T, Krauss-Etschmann S, Buschmann D, Behrends J, Watz H, Kirsten A-M, et al. RNA-seq-based profiling of extracellular vesicles in plasma reveals a potential role of miR-122-5p in asthma. Allergy. 2021;76(1):366–71.CrossRef
54.
Kyyaly MA, Sanchez-Elsner T, He P, Sones CL, Arshad SH, Kurukulaaratchy RJ. Circulating miRNAs-A potential tool to identify severe asthma risk? Clin Transl Allergy. 2021;11(4):e12040.CrossRef
55.
Atashbasteh M, Mortaz E, Mahdaviani SA, Jamaati H, Allameh A. Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors. Allergy Asthma Clin Immunol. 2021;17(1):51.CrossRef
56.
Rial MJ, Cañas JA, Rodrigo-Muñoz JM, Valverde-Monge M, Sastre B, Sastre J, et al. Changes in serum MicroRNAs after anti-IL-5 biological treatment of severe asthma. Int J Mol Sci. 2021;22(7):3558.CrossRef
57.
Wang W, Wang J, Chen H, Zhang X, Han K. Downregulation of miR-3934 in peripheral blood mononuclear cells of asthmatic patients and its potential diagnostic value. Biomed Res Int. 2021;2021:8888280.
58.
ElKashef SMMAE, Ahmad SEA, Soliman YMA, Mostafa MS. Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma. Innate Immun. 2021;27(1):61–9.CrossRef
59.
Cañas JA, Valverde-Monge M, Rodrigo-Muñoz JM, Sastre B, Gil-Martínez M, García-Latorre R, et al. Serum microRNAs as tool to predict early response to benralizumab in severe eosinophilic asthma. J Pers Med. 2021;11(2):76.CrossRef
60.
Wardzyńska A, Pawełczyk M, Rywaniak J, Makowska J, Jamroz-Brzeska J, Kowalski ML. Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation. Respir Res. 2021;22(1):177.CrossRef
61.
Yu Y, Men S, Zhang Y. miR-20a-5p ameliorates ovalbumin (OVA)-induced mouse model of allergic asthma through targeting ATG7-regulated cell death, fibrosis and inflammation. Int Immunopharmacol. 2021;95:107342.CrossRef
62.
Liu S, Chen X, Zhang S, Wang X, Du X, Chen J, et al. miR-106b-5p targeting SIX1 inhibits TGF-β1-induced pulmonary fibrosis and epithelial-mesenchymal transition in asthma through regulation of E2F1. Int J Mol Med. 2021;47(3):1.CrossRef
63.
Wang J-Y, Dong X, Yu Z, Ge L, Lu L, Ding L, et al. Borneol inhibits CD4 + T cells proliferation by down-regulating miR-26a and miR-142-3p to attenuate asthma. Int Immunopharmacol. 2021;90:107223.CrossRef
64.
Dai J, Ma B, Wen X, Yang Z, Yue Y. Upregulation of miR-92a contributes to blocking goblet cell metaplasia by targeting MUC5AC in asthma. J Recept Signal Transduct Res. 2020;40(6):613–9.CrossRef
65.
Zou Y, Zhou Q, Zhang Y. MicroRNA-21 released from mast cells-derived extracellular vesicles drives asthma in mice by potentiating airway inflammation and oxidative stress. Am J Transl Res. 2021;13(7):7475–91.
66.
Li X, Yang N, Cheng Q, Zhang H, Liu F, Shang Y. MiR-21-5p in macrophage-derived exosomes targets Smad7 to promote epithelial mesenchymal transition of airway epithelial cells. J Asthma Allergy. 2021;14:513–24.CrossRef
67.
Li C, Deng C, Zhou T, Hu J, Dai B, Yi F, et al. MicroRNA-370 carried by M2 macrophage-derived exosomes alleviates asthma progression through inhibiting the FGF1/MAPK/STAT1 axis. Int J Biol Sci. 2021;17(7):1795–807.CrossRef
68.
69.
Chen H, Guo S-X, Zhang S, Li X-D, Wang H, Li X-W. MiRNA-620 promotes TGF-β1-induced proliferation of airway smooth muscle cell through controlling PTEN/AKT signaling pathway. Kaohsiung J Med Sci. 2020;36(11):869–77.CrossRef
70.
Chen D, Wu W, Yi L, Feng Y, Chang C, Chen S, et al. A potential circRNA-miRNA-mRNA regulatory network in asthmatic airway epithelial cells identified by integrated analysis of microarray datasets. Front Mol Biosci. 2021;8:703307.CrossRef
71.
Lee HY, Hur J, Kang JY, Rhee CK, Lee SY. MicroRNA-21 inhibition suppresses alveolar M2 macrophages in an ovalbumin-induced allergic asthma mice model. Allergy Asthma Immunol Res. 2021;13(2):312–29.CrossRef
72.
Hur J, Rhee CK, Lee SY, Kim YK, Kang JY. MicroRNA-21 inhibition attenuates airway inflammation and remodelling by modulating the transforming growth factor β-Smad7 pathway. Korean J Intern Med. 2021;36(3):706–20.CrossRef
73.
Huang W, Yu C, Liang S, Wu H, Zhou Z, Liu A, et al. Long non-coding RNA TUG1 promotes airway remodeling and mucus production in asthmatic mice through the microRNA-181b/HMGB1 axis. Int Immunopharmacol. 2021;94:107488.CrossRef
74.
Wang W, Guo J, Wang Y. MicroRNA-30b-5p promotes the proliferation and migration of human airway smooth muscle cells induced by platelet-derived growth factor by targeting phosphatase and tensin homolog deleted on chromosome ten. Bioengineered. 2021;12(1):3662–73.CrossRef
75.
Magnaye KM, Naughton KA, Huffman J, Hogarth DK, Naureckas ET, White SR, et al. A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma. Eur Respir J. 2021;58(1):2003862.CrossRef
76.
Chiba Y, Ando Y, Kato Y, Hanazaki M, Sakai H. Down-regulation of miR-140–3p is a cause of the interlukin-13-induced up-regulation of RhoA protein in bronchial smooth muscle cells. Small GTPases. 2021;1–6.
77.
Chiba Y, Ando Y, Fujii S, Miyakawa Y, Suto W, Kamei J, et al. Downregulation of miR-140-3p is a cause of upregulation of RhoA protein in bronchial smooth muscle of murine experimental asthma. Am J Respir Cell Mol Biol. 2021;64(1):138–40.CrossRef
78.
Zhu Z, Zhang L, Jiang T, Qian Y, Sun Y, Zhang Q. MiR-149 attenuates the proliferation and migration of TGF-β1-induced airway smooth muscle cells by targeting TRPM7 and affecting downstream MAPK signal pathway. Acta Biochim Pol. 2020;67(4):453–60.
79.
Huang X-P, Qin C-Y, Gao Y-M. miR-135a inhibits airway inflammatory response in asthmatic mice via regulating JAK/STAT signaling pathway. Braz J Med Biol Res. 2021;54(3):e10023.CrossRef
80.
Shi J, Chen M, Ouyang L, Wang Q, Guo Y, Huang L, et al. miR-142-5p and miR-130a-3p regulate pulmonary macrophage polarization and asthma airway remodeling. Immunol Cell Biol. 2020;98(9):715–25.CrossRef
81.
Wongtrakool C, Ko J, Jang AJ, Grooms K, Chang S, Sylber C, et al. MicroRNA-98 reduces nerve growth factor expression in nicotine-induced airway remodeling. J Biol Chem. 2020;295(52):18051–64.CrossRef
82.
Zhai W, Sun H, Li Z, Li L, Jin A, Li Y, et al. PRMT1 modulates processing of asthma-related primary MicroRNAs (pri-miRNAs) into mature miRNAs in lung epithelial cells. J Immunol. 2021;206(1):11–22.CrossRef
83.
Cai X-J, Huang L-H, Zhu Y-K, Huang Y-J. LncRNA OIP5-AS1 aggravates house dust mite-induced inflammatory responses in human bronchial epithelial cells via the miR-143-3p/HMGB1 axis. Mol Med Rep. 2020;22(6):4509–18.CrossRef
84.
Yan F, Wufuer D, Ding J, Wang J. MicroRNA miR-146a-5p inhibits the inflammatory response and injury of airway epithelial cells via targeting TNF receptor-associated factor 6. Bioengineered. 2021;12(1):1916–26.CrossRef
85.
Zhang K, Feng Y, Liang Y, Wu W, Chang C, Chen D, et al. Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma. JCI Insight. 2021;6(11).
86.
Siddiqui S, Johansson K, Joo A, Bonser LR, Koh KD, Le Tonqueze O, et al. Epithelial miR-141 regulates IL-13-induced airway mucus production. JCI Insight. 2021;6(5).
87.
Ma L, Zhang Q, Hao J, Wang J, Wang C. LncRNA PVT1 exacerbates the inflammation and cell-barrier injury during asthma by regulating miR-149. J Biochem Mol Toxicol. 2020;34(11):e22563.CrossRef
88.
Wei Y, Han B, Dai W, Guo S, Zhang C, Zhao L, et al. Exposure to ozone impacted Th1/Th2 imbalance of CD4+ T cells and apoptosis of ASMCs underlying asthmatic progression by activating lncRNA PVT1-miR-15a-5p/miR-29c-3p signaling. Aging (Albany NY). 2020;12(24):25229–55.CrossRef
89.
Sun H, Wang T, Zhang W, Dong H, Gu W, Huang L, et al. LncRNATUG1 facilitates Th2 cell differentiation by targeting the miR-29c/B7-H3 axis on macrophages. Front Immunol. 2021;12:631450.CrossRef
90.
Wang T, Wang P, Chen D, Xu Z, Yang L. circARRDC3 contributes to interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells via the miR-375/KLF4 axis. Mol Med Rep. 2021;23(2):1.
91.
Hirai K, Shirai T, Shimoshikiryo T, Ueda M, Gon Y, Maruoka S, et al. Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap. Allergy. 2021;76(3):766–74.CrossRef
92.
Bersimbaev R, Aripova A, Bulgakova O, Kussainova A, Akparova A, Izzotti A. The plasma levels of hsa-miR-19b-3p, hsa-miR-125b-5p, and hsamiR- 320c in patients with asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). MicroRNA. 2021;10(2):130–8.CrossRef
93.
Jartti T, Bønnelykke K, Elenius V, Feleszko W. Role of viruses in asthma. Semin Immunopathol. 2020;42(1):61–74.CrossRef
94.
Liu C-C, Miao Y, Chen R-L, Zhang Y-Q, Wu H, Yang S-M, et al. STIM1 mediates IAV-induced inflammation of lung epithelial cells by regulating NLRP3 and inflammasome activation via targeting miR-223. Life Sci. 2021;266:118845.CrossRef
95.
Du X, Yang Y, Xiao G, Yang M, Yuan L, Qin L, et al. Respiratory syncytial virus infection-induced mucus secretion by down-regulation of miR-34b/c-5p expression in airway epithelial cells. J Cell Mol Med. 2020;24(21):12694–705.CrossRef
96.
Collison AM, Sokulsky LA, Kepreotes E, de Siqueira A, Morten M, Edwards MR, et al. miR-122 promotes virus-induced lung disease by targeting SOCS1. JCI Insight. 2021;6(7).
97.
Laanesoo A, Urgard E, Periyasamy K, Laan M, Bochkov YA, Aab A, et al. Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation. Clin Transl Med. 2021;11(6):e427.CrossRef
Metadata
Title
Recent miRNA Research in Asthma
Authors
Rinku Sharma
Anshul Tiwari
Michael J. McGeachie
Publication date
02-12-2022
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 12/2022
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-022-01050-1

Other articles of this Issue 12/2022

Current Allergy and Asthma Reports 12/2022 Go to the issue

Anaphylaxis and Drug Allergy (M Castells, Section Editor)

Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases

Occupational Allergies (JA Poole, Section Editor)

A Clinician’s Guide to Occupational Exposures in the Military

Allergies and the Environment (T Moran, Section Editor)

Nature with Nurture: the Role of Intrinsic Genetic and Extrinsic Environmental Factors on Eosinophilic Esophagitis

Autoimmunity (TK Tarrant, Section Editor)

Cardiac Sarcoidosis: Current Approaches to Diagnosis and Management

Asthma (V Ortega, Section Editor)

Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis

Allergic Skin Diseases (L Fonacier, Section Editor)

Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases